Paradifference Foundation UK
Registered charity 1189004 CIO Registered since 2020
Operates: Throughout England And Wales, United States, Sweden, Italy, Spain, Germany, Netherlands, France, Australia
Connected trustee network
The connection graph needs a free account.
This charity's record is public. The network of who else its trustees govern is compiled from the registers by us, and an account keeps it out of bulk scrapers.
Sign in, freeBoard DNA
How this board is put together, from Charity Commission trustee records and Companies House - deterministic, no AI.
Sector coverage
Gaps to watch
- No commercial or business experience on the board
- Several long-serving trustees could step down together
- Narrow spread of causes across the board
Related organisations
- Hyperlipidaemia Education & Atherosclerosis Research Trust UK Similar size; both Health
- Tynedale Hospice AT Home Similar size; both Health
- East Suffolk and North Essex NHS Foundation Trust Charitable Funds Similar size; both Health
- The British Orthodontic Society Similar size; both Health
- Warren House Group AT Dartington Similar size; both Health
- Havering Mind Similar size; both Health
Boards that overlap with this one through shared trustees, or govern in the same field. Deterministic, from public records.
Contact
| paradifference@gmail.com | |
| Phone | +447572290523 |
| Address | One Bartholomew Close, London, EC1A 7BL |
Finances
£1,599,606 latest income
| Year | Income | Spending |
|---|---|---|
| 2021 | £500 | £48 |
| 2022 | £723,027 | £9,530 |
| 2023 | £804,288 | £663,772 |
| 2024 | £1,624,830 | £543,236 |
| 2025 | £1,599,606 | £1,474,612 |
What it does
What
Education/trainingThe Advancement Of Health Or Saving Of LivesWho
The General Public/mankindHow
Makes Grants To IndividualsMakes Grants To OrganisationsSponsors Or Undertakes ResearchCharitable objects
3.1 THE OBJECTS OF THE CIO ARE:(A) TO ADVANCE THE EDUCATION OF THE PUBLIC IN GENERAL AND TO PROMOTE MEDICAL RESEARCH RELATED TO NEUROENDOCRINE CANCERS (PARTICULARLY PARAGANGLIOMA AND PHEOCHROMOCYTOMA, WITH SPECIAL REGARD TO MALIGNANT PARAGANGLIOMAS CAUSED BY THE SDHB MUTATION) FOR THE PUBLIC BENEFIT.(B) TO ADVANCE HEALTH BY SUPPORTING EFFORTS TO IMPROVE TREATMENT OPTIONS FOR PEOPLE WITH NEUROENDOCRINE CANCERS.(C) TO ADVANCE SCIENCE BY INCREASING THE EXISTING BODY OF KNOWLEDGE IN RELATION TO THE UNDERSTANDING, DIAGNOSIS, MANAGEMENT AND TREATMENT OF NEUROENDOCRINE CANCERS.
Governing document: CIO - FOUNDATION Registered 09 Apr 2020
Trustees (4)
- Anna-Karin Gustavsson Chair since 2019
- Anna Amanda Marcusdotter Dusing since 2019
- Claes Marcus Lennart Gustavsson since 2019
- Professor Randall Scott Johnson Ph.D since 2019
Connected charities (0)
No charities share a trustee (from current data).
For recruiters
Tools for approaching charities and finding candidates. In development - register to get early access.
Report an error in this record - let us know.
Related record